The Medicines for Human Use (Clinical Trials) Regulations 2004 No. 1031

SCHEDULE 3 PARTICULARS AND DOCUMENTS THAT MUST ACCOMPANY AN APPLICATION FOR AN ETHICS COMMITTEE OPINION, A REQUEST FOR AUTHORISATION, A NOTICE OF AMENDMENT AND A NOTIFICATION OF THE CONCLUSION OF A TRIAL

PART 4 NOTIFICATION OF CONCLUSION OF A CLINICAL TRIAL

5.  If the trial is terminated as specified in regulation 27(2), the reasons for terminating the trial early.